Synopsis of recent research by authors named "Liangtao Zheng"
- Liangtao Zheng's recent research predominantly focuses on the roles and dynamics of T cells in tumor immunology, with particular attention to their heterogeneous populations and responses in various cancer types, as seen in articles like "Pan-cancer single-cell landscape of tumor-infiltrating T cells" and "Lineage tracking reveals dynamic relationships of T cells in colorectal cancer."
- His work also explores innovative treatment combinations to enhance anti-tumor efficacy, particularly in Hodgkin lymphoma, by evaluating triplet regimens that include epigenetic agents combined with immunotherapy, as described in "Epigenetic agents plus anti-PD-1 reprogram the tumor microenvironment."
- Zheng has developed advanced computational tools for analyzing single-cell RNA sequencing data, such as the STARTRAC framework that tracks T cell lineages, and introduced the SSCC clustering algorithm for large-scale datasets, highlighting his contributions to both experimental and technological advancements in cancer research.